Simplex Trading’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLRX
TCM
ACM
MAM
LCM
BCM
Simplex Trading's PLRX Position: Q2 2026 in Review
Simplex Trading reduced its Pliant Therapeutics (PLRX) stake by 90% in Q2 2026, selling an estimated $52.5K and leaving 4,925 shares worth $5.61K. The position accounts for ﹤0.01% of the portfolio, ranked #8102.
Simplex Trading first reported a position in PLRX in Q1 2022 and has held it in 16 quarters since. The position peaked at $444K in Q3 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.
- Simplex Trading held 4,925 shares of Pliant Therapeutics worth $5.61K as of Q2 2026.
- Simplex Trading sold 43,129 Pliant Therapeutics shares in Q2 2026, an estimated $52.5K.
- Pliant Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8102 holding.
- Simplex Trading first reported a position in Pliant Therapeutics in Q1 2022 and has held it in 16 quarters since.
- Simplex Trading's Pliant Therapeutics position peaked at $444K in Q3 2023.
- 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.